12/4
07:18 am
evmn
Evommune (NYSE:EVMN) was upgraded by analysts at Zacks Research to a "hold" rating.
Medium
Report
Evommune (NYSE:EVMN) was upgraded by analysts at Zacks Research to a "hold" rating.
12/3
07:57 am
evmn
Evommune (NYSE:EVMN) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Low
Report
Evommune (NYSE:EVMN) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
12/2
06:16 am
evmn
Evommune (NYSE:EVMN) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Medium
Report
Evommune (NYSE:EVMN) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
12/1
08:09 am
evmn
Evommune (NYSE:EVMN) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $42.00 price target on the stock.
Low
Report
Evommune (NYSE:EVMN) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $42.00 price target on the stock.
12/1
07:20 am
evmn
Evommune (NYSE:EVMN) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
Low
Report
Evommune (NYSE:EVMN) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
12/1
07:03 am
evmn
Evommune (NYSE:EVMN) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Low
Report
Evommune (NYSE:EVMN) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
12/1
06:04 am
evmn
Evommune (NYSE:EVMN) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Low
Report
Evommune (NYSE:EVMN) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
12/1
05:12 am
evmn
Evommune (NYSE:EVMN) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
Low
Report
Evommune (NYSE:EVMN) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
11/20
10:06 pm
evmn
Low
Report
11/5
07:45 pm
evmn
Evommune Announces Pricing of its Initial Public Offering
High
Report
Evommune Announces Pricing of its Initial Public Offering